Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Steg

Showing results (471-480 of 962) with videos related to

Pageof 97
Sort By:
American Heart Journal|March 1, 2006
The diagnostic and prognostic impact of the redefinition of acute myocardial infarction: lessons from the Global Registry of Acute Coronary Events (GRACE)Shaun G Goodman, Philippe Gabriel Steg, Kim A Eagle, et al.
JACC. Cardiovascular Interventions|July 20, 2013
Angiographic outcomes in the PLATO Trial (Platelet Inhibition and Patient Outcomes)Vijay Kunadian, Stefan K James, Daniel M Wojdyla, et al.
American Heart Journal|May 21, 2019
Ticagrelor in patients with heart failure after acute coronary syndromes-Insights from the PLATelet inhibition and patient Outcomes (PLATO) trialAxel Åkerblom, Daniel M Wojdyla, Lars Wallentin, et al.
Circulation. Cardiovascular Interventions|January 12, 2021
Sex Differences in Ischemic and Bleeding Outcomes in Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Insights From the TAO TrialJean-Guillaume Dillinger, Gregory Ducrocq, Yedid Elbez, et al.
Journal of the American College of Cardiology|October 30, 2012
Effects of radial versus femoral artery access in patients with acute coronary syndromes with or without ST-segment elevationShamir R Mehta, Sanjit S Jolly, John Cairns, et al.
Circulation. Cardiovascular Interventions|June 18, 2016
Variation in Patient Profiles and Outcomes in US and Non-US Subgroups of the Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION) PHOENIX TrialMuthiah Vaduganathan, Robert A Harrington, Gregg W Stone, et al.
Archives of Cardiovascular Diseases|February 26, 2025
Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation: Rationale for and design of the AQUATIC double-blind randomized trialRomain Didier, Gilles Lemesle, Gilles Montalescot, et al.
Journal of the American Heart Association|May 6, 2020
Gut Microbiota-Dependent Trimethylamine N-oxide and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: A Nested Case Control Study From the PEGASUS-TIMI 54 TrialBaris Gencer, Xinmin S Li, Yared Gurmu, et al.
European Stroke Journal|June 6, 2019
Non-cardioembolic stroke/transient ischaemic attack in Asians and non-Asians: A post-hoc analysis of the PERFORM studyTakao Hoshino, Leila Sissani, Julien Labreuche, et al.
The American Journal of Cardiology|August 14, 2017
Cangrelor Versus Clopidogrel on a Background of Unfractionated Heparin (from CHAMPION PHOENIX)Muthiah Vaduganathan, Robert A Harrington, Gregg W Stone, et al.
Pageof 97

Showing results (471-480 of 962) with videos related to

Sort By:
Pageof 97
American Heart Journal|March 1, 2006
The diagnostic and prognostic impact of the redefinition of acute myocardial infarction: lessons from the Global Registry of Acute Coronary Events (GRACE)Shaun G Goodman, Philippe Gabriel Steg, Kim A Eagle, et al.
JACC. Cardiovascular Interventions|July 20, 2013
Angiographic outcomes in the PLATO Trial (Platelet Inhibition and Patient Outcomes)Vijay Kunadian, Stefan K James, Daniel M Wojdyla, et al.
American Heart Journal|May 21, 2019
Ticagrelor in patients with heart failure after acute coronary syndromes-Insights from the PLATelet inhibition and patient Outcomes (PLATO) trialAxel Åkerblom, Daniel M Wojdyla, Lars Wallentin, et al.
Circulation. Cardiovascular Interventions|January 12, 2021
Sex Differences in Ischemic and Bleeding Outcomes in Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Insights From the TAO TrialJean-Guillaume Dillinger, Gregory Ducrocq, Yedid Elbez, et al.
Journal of the American College of Cardiology|October 30, 2012
Effects of radial versus femoral artery access in patients with acute coronary syndromes with or without ST-segment elevationShamir R Mehta, Sanjit S Jolly, John Cairns, et al.
Circulation. Cardiovascular Interventions|June 18, 2016
Variation in Patient Profiles and Outcomes in US and Non-US Subgroups of the Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION) PHOENIX TrialMuthiah Vaduganathan, Robert A Harrington, Gregg W Stone, et al.
Archives of Cardiovascular Diseases|February 26, 2025
Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation: Rationale for and design of the AQUATIC double-blind randomized trialRomain Didier, Gilles Lemesle, Gilles Montalescot, et al.
Journal of the American Heart Association|May 6, 2020
Gut Microbiota-Dependent Trimethylamine N-oxide and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: A Nested Case Control Study From the PEGASUS-TIMI 54 TrialBaris Gencer, Xinmin S Li, Yared Gurmu, et al.
European Stroke Journal|June 6, 2019
Non-cardioembolic stroke/transient ischaemic attack in Asians and non-Asians: A post-hoc analysis of the PERFORM studyTakao Hoshino, Leila Sissani, Julien Labreuche, et al.
The American Journal of Cardiology|August 14, 2017
Cangrelor Versus Clopidogrel on a Background of Unfractionated Heparin (from CHAMPION PHOENIX)Muthiah Vaduganathan, Robert A Harrington, Gregg W Stone, et al.
Pageof 97